All Stories

  1. A novel self-transmissible mega plasmid from extensively drug-resistant Klebsiella oxytoca carries multiple antimicrobial resistance genes and acts as a resistance reservoir
  2. Cationic metal-binding coumarin amphiphiles as membrane-active antimicrobial agents
  3. The effect of commonly used non-antibiotic medications on antimicrobial resistance development in Escherichia coli
  4. Lacritin cleavage-potentiated targeting of iron - respiratory reciprocity promotes bacterial death
  5. Identification of a Potential High-Risk Clone and Novel Sequence Type of Carbapenem-Resistant Pseudomonas aeruginosa in Metro Manila, Philippines
  6. The continued evolution of the L2 cephalosporinase in Stenotrophomonas maltophilia: a key driver of beta-lactam resistance
  7. Commonly used non-antibiotic medications promote mutation frequency and antimicrobial resistance inEscherichia coli
  8. Enterobacter adelaidei sp. nov. Isolation of an extensively drug resistant strain from hospital wastewater in Australia and the global distribution of the species
  9. Identification of potential high-risk clones of Carbapenem-ResistantPseudomonas aeuroginosaco-producing, KPC-2, VIM-2 and OXA-74 from tertiary hospitals in Metro Manila, Philippines
  10. New antibiotics to combat One Health AMR
  11. Multidrug‐resistant Stenotrophomonas maltophilia in residential aged care facilities: An emerging threat
  12. Resistome Analysis of Klebsiella pneumoniae Complex from Residential Aged Care Facilities Demonstrates Intra-facility Clonal Spread of Multidrug-Resistant Isolates
  13. Identification and characterization of CIM-1, a carbapenemase that adds to the family of resistance factors against last resort antibiotics
  14. Identification and evolution of ICE-PmuST394: a novel integrative conjugative element in Pasteurella multocida ST394
  15. Recommendations of Key Elements within an Integrated Monitoring Framework of Antimicrobial Resistance for Asian Countries
  16. The scope of antimicrobial resistance in residential aged care facilities determined through analysis of Escherichia coli and the total wastewater resistome
  17. Orthogonal Reversed-Phase C18 and Pentafluorophenyl HPLC Separation for Phytochemical Profiling of Serrulatanes in Eremophila denticulata
  18. Combined Structure- and Ligand-Based Approach for the Identification of Inhibitors of AcrAB-TolC in Escherichia coli
  19. Oral administration of a 2-aminopyrimidine robenidine analogue (NCL195) significantly reduces Staphylococcus aureus infection and reduces Escherichia coli infection in combination with sub-i...
  20. Genomic profiling of Pasteurella multocida isolated from feedlot cases of bovine respiratory disease
  21. Adding to the family of resistance factors against last resort antibiotics: Identification and characterization of a novel carbapenemase, CIM-1
  22. Design and synthesis of benzochromene derivatives as AcrB inhibitors for the reversal of bacterial multidrug resistance
  23. Polypharmacology-Labeled Molecular Networking: An Analytical Technology Workflow for Accelerated Identification of Multiple Bioactive Constituents in Complex Extracts
  24. Targeting malaria parasites with novel derivatives of azithromycin
  25. In Vitro Activity of Robenidine Analogues NCL259 and NCL265 against Gram-Negative Pathogens
  26. Cinnamaldehyde derivatives act as antimicrobial agents against Acinetobacter baumannii through the inhibition of cell division
  27. Antimicrobial susceptibility and genomic analysis of Histophilus somni isolated from cases of bovine respiratory disease in Australian feedlot cattle
  28. Lacritin Bactericidal Peptide N‐104 Targeting of Inner Membrane Transporters FeoB and PotH (SpuG) Individually Absent in N‐104 Resistant Strains of Human Opportunistic Pathogen, P. aeruginosa PA14
  29. Correction: Alhamami et al. First Emergence of Resistance to Macrolides and Tetracycline Identified in Mannheimia haemolytica and Pasteurella multocida Isolates from Beef Feedlots in Australia. Microorganisms 2021, 9, 1322
  30. The Structural and Functional Study of Efflux Pumps Belonging to the RND Transporters Family from Gram-Negative Bacteria
  31. Complete Genome Sequence of Pasteurella multocida Sequence Type 394, Isolated from a Case of Bovine Respiratory Disease in Australia
  32. Impact of a Novel Anticoccidial Analogue on Systemic Staphylococcus aureus Infection in a Bioluminescent Mouse Model
  33. Worldwide distribution and environmental origin of the Adelaide imipenemase (AIM-1), a potent carbapenemase in Pseudomonas aeruginosa
  34. Bioactivity-guided isolation of compounds from Sophora flavescens with antibacterial activity against Acinetobacter baumannii
  35. An optimized and robust PEG precipitation method for detection of SARS-CoV-2 in wastewater
  36. Taking AIM-(1) at carbapenem resistance in Pseudomonas aeruginosa
  37. Repurposing of the Fasciolicide Triclabendazole to Treat Infections Caused by Staphylococcus spp. and Vancomycin-Resistant Enterococci
  38. SdiA, a Quorum-Sensing Regulator, Suppresses Fimbriae Expression, Biofilm Formation, and Quorum-Sensing Signaling Molecules Production in Klebsiella pneumoniae
  39. First Emergence of Resistance to Macrolides and Tetracycline Identified in Mannheimia haemolytica and Pasteurella multocida Isolates from Beef Feedlots in Australia
  40. Evaluation of Benzguinols as Next-Generation Antibiotics for the Treatment of Multidrug-Resistant Bacterial Infections
  41. Protective role of PhtD and its amino and carboxyl fragments against pneumococcal sepsis
  42. In vitro synergistic activity of NCL195 in combination with colistin against Gram-negative bacterial pathogens
  43. Comparison of Two Transmission Electron Microscopy Methods to Visualize Drug-Induced Alterations of Gram-Negative Bacterial Morphology
  44. Design and structural optimization of novel 2H-benzo[h]chromene derivatives that target AcrB and reverse bacterial multidrug resistance
  45. A pH-neutral electrolyzed oxidizing water significantly reduces microbial contamination of fresh spinach leaves
  46. Neutral electrolyzed oxidizing water is effective for pre-harvest decontamination of fresh produce
  47. Catecholic alkaloid sulfonates and aromatic nitro compounds from Portulaca oleracea and screening of their anti-inflammatory and anti-microbial activities
  48. Antimicrobial Action and Reversal of Resistance in MRSA by Difluorobenzamide Derivatives Targeted at FtsZ
  49. Design and synthesis of aryl-substituted pyrrolidone derivatives as quorum sensing inhibitors
  50. Design and synthesis of novel 4-substituted quinazoline-2-carboxamide derivatives targeting AcrB to reverse the bacterial multidrug resistance
  51. Efflux Pump-Driven Antibiotic and Biocide Cross-Resistance in Pseudomonas aeruginosa Isolated from Different Ecological Niches: A Case Study in the Development of Multidrug Resistance in Environmental Hotspots
  52. In vitro Activity of Robenidine Analog NCL195 in Combination With Outer Membrane Permeabilizers Against Gram-Negative Bacterial Pathogens and Impact on Systemic Gram-Positive Bacterial Infection in Mice
  53. Structural optimization of natural product nordihydroguaretic acid to discover novel analogues as AcrB inhibitors
  54. Comparative antibacterial activities of neutral electrolyzed oxidizing water and other chlorine-based sanitizers
  55. Disinfection options for irrigation water: Reducing the risk of fresh produce contamination with human pathogens
  56. Measuring Small Molecule Binding to Escherichia coli AcrB by Surface Plasmon Resonance
  57. Allicin prevents the formation of Proteus-induced urinary crystals and the blockage of catheter in a bladder model in vitro
  58. Antimicrobial effects of cinnamon essential oil and cinnamaldehyde combined with EDTA against canine otitis externa pathogens
  59. In vitro Antimicrobial Activity of Robenidine, Ethylenediaminetetraacetic Acid and Polymyxin B Nonapeptide Against Important Human and Veterinary Pathogens
  60. Reversing resistance to counter antimicrobial resistance in the World Health Organisation’s critical priority of most dangerous pathogens
  61. Design, synthesis and evaluation of a series of 5-methoxy-2,3-naphthalimide derivatives as AcrB inhibitors for the reversal of bacterial resistance
  62. Design, synthesis and structure-based optimization of novel isoxazole-containing benzamide derivatives as FtsZ modulators
  63. Induction of Escherichia coli into a VBNC state through chlorination/chloramination and differences in characteristics of the bacterium between states
  64. Bioluminescent murine models of bacterial sepsis and scald wound infections for antimicrobial efficacy testing
  65. Genomic characterization of coagulase-negative staphylococci including methicillin-resistant Staphylococcus sciuri causing bovine mastitis
  66. Novel 5-methyl-2-phenylphenanthridium derivatives as FtsZ-targeting antibacterial agents from structural simplification of natural product sanguinarine
  67. Kinetic analysis of the inhibition of the drug efflux protein AcrB using surface plasmon resonance
  68. Substitution of terminal amide with 1 H -1,2,3-triazole: Identification of unexpected class of potent antibacterial agents
  69. Design, synthesis and biological activity evaluation of novel 4-subtituted 2-naphthamide derivatives as AcrB inhibitors
  70. Efficacy evaluation of a new water sanitizer for increasing the shelf life of Southern Australian King George Whiting and Tasmanian Atlantic Salmon fillets
  71. Evaluation of robenidine analog NCL195 as a novel broad-spectrum antibacterial agent
  72. Synthesis and antibacterial activity of 5-methylphenanthridium derivatives as FtsZ inhibitors
  73. Antimicrobial resistance in healthcare, agriculture and the environment: the biochemistry behind the headlines
  74. Intrinsic, adaptive and acquired antimicrobial resistance in Gram-negative bacteria
  75. Design, synthesis and biological activity evaluation of novel 2,6-difluorobenzamide derivatives through FtsZ inhibition
  76. Evaluation of a series of 2-napthamide derivatives as inhibitors of the drug efflux pump AcrB for the reversal of antimicrobial resistance
  77. Synthesis and antibacterial activity of novel 3- O -descladinosylazithromycin derivatives
  78. Bio-augmentation and nutrient amendment decrease concentration of mercury in contaminated soil
  79. Structural model of FeoB, the iron transporter from Pseudomonas aeruginosa, predicts a cysteine lined, GTP-gated pore
  80. Efflux Pump Inhibitors: A Novel Approach to Combat Efflux-Mediated Drug Resistance in Bacteria
  81. Synthesis and Biological Evaluation of Novel FtsZ‐targeted 3‐arylalkoxy‐2,6‐difluorobenzamides as Potential Antimicrobial Agents
  82. RND-type drug efflux pumps from Gram-negative bacteria: molecular mechanism and inhibition
  83. Phytochemicals increase the antibacterial activity of antibiotics by acting on a drug efflux pump
  84. Expression, purification and functional reconstitution of FeoB, the ferrous iron transporter from Pseudomonas aeruginosa
  85. Structure of the AcrAB–TolC multidrug efflux pump
  86. Mutations in MexB that affect the efflux of antibiotics with cytoplasmic targets
  87. Promiscuous partnering and independent activity of MexB, the multidrug transporter protein from Pseudomonas aeruginosa
  88. A Multidrug ABC Transporter with a Taste for Salt
  89. Mass spectrometry of membrane transporters reveals subunit stoichiometry and interactions
  90. On the energy-dependence of Hoechst 33342 transport by the ABC transporter LmrA
  91. Two Proton Translocation Pathways in a Secondary Active Multidrug Transporter
  92. New light on multidrug binding by an ATP-binding-cassette transporter
  93. Similarities between ATP-dependent and ion-coupled multidrug transporters
  94. Drug-Lipid A Interactions on the Escherichia coli ABC Transporter MsbA
  95. A critical role of a carboxylate in proton conduction by the ATP‐binding cassette multidrug transporter LmrA
  96. Arginine-482 is not essential for transport of antibiotics, primary bile acids and unconjugated sterols by the human breast cancer resistance protein (ABCG2)
  97. Reversible Transport by the ATP-binding Cassette Multidrug Export Pump LmrA
  98. Purification and properties of theEscherichia colinucleoside transporter NupG, a paradigm for a major facilitator transporter sub-family
  99. An ABC transporter with a secondary-active multidrug translocator domain
  100. A new dimer interface for an ABC transporter
  101. The ATP Binding Cassette Multidrug Transporter LmrA and Lipid Transporter MsbA Have Overlapping Substrate Specificities
  102. Sterol Transport by the Human Breast Cancer Resistance Protein (ABCG2) Expressed in Lactococcus lactis
  103. Molecular dissection of membrane-transport proteins: mass spectrometry and sequence determination of the galactose‒H+ symport protein, GalP, of Escherichia coli and quantitative assay of the incorporation of [ring-2-13C]histidine and 15NH3
  104. Do mammals make their own morphine?
  105. Expression of prokaryotic membrane transport proteins in Escherichia coli
  106. Purification and Characterization of a Metalloprotease fromChryseobacterium indologenesIx9a and Determination of the Amino Acid Specificity with Electrospray Mass Spectrometry
  107. Equipping a Research Scale Fermentation Laboratory for Production of Membrane Proteins